All Stories

  1. Can cardiovascular drugs support cancer treatment? The rationale for drug repurposing

    Article • Drug Discovery Today, April 2019, Elsevier

    dr Miłosz J. Regulski

  2. Synthesis, in vitro and in silico evaluation of novel trans -stilbene analogues as potential COX-2 inhibitors

    Article • Bioorganic & Medicinal Chemistry, January 2018, Elsevier

    dr Miłosz J. Regulski

  3. Risks of nutritional supplements consumption by pregnant women

    Article • Journal of Medical Science, March 2017, Poznan University of Medical Sciences

    dr Miłosz J. Regulski

  4. How to stabilize cilazapril-containing solid dosage forms? The optimization of a final drug formulation

    Article • Arabian Journal of Chemistry, March 2017, Elsevier

    dr Miłosz J. Regulski

  5. Unknown face of known drugs – what else can we expect from angiotensin converting enzyme inhibitors?

    Article • European Journal of Pharmacology, February 2017, Elsevier

    dr Miłosz J. Regulski

  6. COX-2 inhibitors: a novel strategy in the management of breast cancer

    Article • Drug Discovery Today, April 2016, Elsevier

    dr Miłosz J. Regulski

  7. Angiotensin-Converting Enzyme Inhibitors

    Article • Current Pharmaceutical Design, March 2015, Bentham Science Publishers

    dr Miłosz J. Regulski

  8. How to design a potent, specific, and stable angiotensin-converting enzyme inhibitor

    Article • Drug Discovery Today, November 2014, Elsevier

    dr Miłosz J. Regulski

  9. The mutagenicity analysis of imidapril hydrochloride and its degradant, diketopiperazine derivative, nitrosation mixtures by in vitro Ames test with two strains of Salmonella typhimurium

    Article • Reports of Practical Oncology & Radiotherapy, November 2014, Elsevier

    dr Miłosz J. Regulski

  10. Molecular fundamentals of drug interactions in the therapy of colorectal cancer

    Article • Postępy Higieny i Medycyny Doświadczalnej, March 2014, Index Copernicus

    dr Miłosz J. Regulski

  11. The Renin-angiotensin System as a Target of Novel Anticancer Therapy

    Article • Current Pharmaceutical Design, December 2013, Bentham Science Publishers

    dr Miłosz J. Regulski

  12. Is there any association between imidapril hydrochloride stability profile under dry air conditions and cancer initiation?

    Article • International Journal of Pharmaceutics, November 2013, Elsevier

    dr Miłosz J. Regulski

  13. Individualization of anticancer therapy; molecular targets of novel drugs in oncology

    Article • Postępy Higieny i Medycyny Doświadczalnej, November 2012, Index Copernicus

    dr Miłosz J. Regulski

  14. Assessing circadian rhythms in propofol PK and PD during prolonged infusion in ICU patients

    Article • Journal of Pharmacokinetics and Pharmacodynamics, June 2010, Springer Science + Business Media

    Dr Pawel Wiczling, dr Miłosz J. Regulski